Results 251 to 260 of about 1,273,827 (295)
Some of the next articles are maybe not open access.

Immunoinformatics in Drug Designing

Immunoinformatics is a sub-branch of immunology that was risen from the huge amount of data generated from tons of genomic and proteomic projects dealing with the host- pathogen interactions in the need of analyzing these data. Immunoinformatics primarily focuses on predicting the algorithmic mapping of epitopes, thus reducing both cost and time ...
Das, Anwesha   +3 more
openaire   +4 more sources

‘Designer Drugs’

Medical Toxicology, 1988
'Designer drugs' are substances intended for recreational use which are derivatives of approved drugs so as to circumvent existing legal restrictions. The term as popularised by the lay press lacks precision. Contrary to the popular belief that 'designer drugs' are original creations, the majority of these agents are 'borrowed' from legitimate ...
J F, Buchanan, C R, Brown
openaire   +2 more sources

Drug Design Issues on the Cell BE

2008
Structure alignment prediction between proteins (protein docking) is crucial for drug design, and a challenging problem for bioinformatics, pharmaceutics, and current and future processors due to it is a very time consuming process. Here, we analyze a well known protein docking application in the Bioinformatic field, Fourier Transform Docking (FTDock),
Harald Servat   +4 more
openaire   +1 more source

Drugs by Design

Scientific American, 1993
C E, Bugg, W M, Carson, J A, Montgomery
openaire   +2 more sources

Antibody–Drug Conjugates: Smart Chemotherapy Delivery Across Tumor Histologies

Ca-A Cancer Journal for Clinicians, 2022
Shanu Modi   +2 more
exaly  

Antiparasitic drug design

Parasitology Today, 1989
D, Hart   +3 more
openaire   +2 more sources

Drug Designing and Drug Delivery

2022
Nahid Rehman, Anjana Pandey
openaire   +1 more source

Drug Design: Designer Drugs

2010
Gerd Folkers, Elvan Kut, Martin Boyer
openaire   +1 more source

Home - About - Disclaimer - Privacy